Purinoceptors in the kidney

Experimental Biology and Medicine

Volumn 232, Issue 6, 2007, Pages 715-726

  Guan, Zhengrong ^a   Osmond, David A ^a   Inscho, Edward W ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Adenosine; ATP; P1 receptors; P2 receptors; Renal autoregulation; Renal microvasculature

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; PURINE P2X RECEPTOR; PURINE P2X1 RECEPTOR; PURINE P2X2 RECEPTOR; PURINE P2X3 RECEPTOR; PURINE P2X4 RECEPTOR; PURINE P2X5 RECEPTOR; PURINE P2X6 RECEPTOR; PURINE P2X7 RECEPTOR; PURINE P2Y RECEPTOR; PURINE P2Y1 RECEPTOR; PURINE P2Y11 RECEPTOR; PURINE P2Y12 RECEPTOR; PURINE P2Y13 RECEPTOR; PURINE P2Y14 RECEPTOR; PURINE P2Y2 RECEPTOR; PURINE P2Y4 RECEPTOR; PURINE P2Y6 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; PURINERGIC RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ARTERIOLE; ARTERY CONSTRICTION; AUTOREGULATION; CAPILLARY PRESSURE; CHRONIC KIDNEY FAILURE; GLOMERULUS; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION RATE; HENLE LOOP; HUMAN; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY CIRCULATION; KIDNEY COLLECTING TUBULE; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY VASCULAR RESISTANCE; MICROCIRCULATION; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PURINE METABOLISM; SHORT SURVEY; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; HUMANS; HYPERTENSION; KIDNEY; RECEPTORS, PURINERGIC P1; RECEPTORS, PURINERGIC P2;

EID: 34249714206     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (143)

1. Burnstock G, Knight GE. Cellular distribution and functions of P2 receptor subtypes in different systems. Int Rev Cytol 240:31-304, 2004.
2. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 233:309-319, 1986.
3. Pearson JD, Gordon JL. P2 purinoceptors in the blood vessel wall. Biochem Pharmacol 38:4157-163, 1989.
4. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev 76:425-536, 1996.
5. Abbracchio MP, Burnstock G. Purinergic signalling: pathophysiological roles. Jpn J Pharmacol 78:113-145, 1998.
6. Kunapuli SP, Daniel JL. P2 receptor subtypes in the cardiovascular system. Biochem J 336(Pt 3):513-523, 1998.
7. Nishiyama A, Rahman M, Inscho EW. Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Hypertens Res 27:791-804, 2004.
8. Boeynaems JM, Communi D, Gonzalez NS, Robaye B. Overview of the P2 receptors. Semin Thromb Hemost 31:139-149, 2005.
9. Gachet C. Regulation of platelet functions by P2 receptors. Annu Rev Pharmacol Toxicol 46:277-300, 2006
10. Burnstock G. Purinergic signalling. Br J Pharmacol 147(Suppl 1):S172-S181, 2006.
11. Williams M, Jarvis MF. Purinergic and pyrimidinergic receptors as potential drug targets. Biochem Pharmacol 59:1173-1185, 2000.
12. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22:364-373, 2002.
13. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC. Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112:358-404, 2006.
14. Chan CM, Unwin RJ, Burnstock G. Potential functional roles of extracellular ATP in kidney and urinary tract. Exp Nephrol 6:200-207, 1998.
15. Turner CM, Vonend O, Chan C, Burnstock G, Unwin RJ. The pattern of distribution of selected ATP-sensitive P2 receptor subtypes in normal rat kidney: an immunohistological study. Cells Tissues Organs 175:105-117, 2003.
16. Unwin RJ, Bailey MA, Burnstock G. Purinergic signaling along the renal tubule: the current state of play. News Physiol Sci 18:237-241, 2003.
17. Bailey MA, Turner CM, Hus-Citharel A, Marchetti J, Imbert-Teboul M, Milner P, Burnstock G, Unwin RJ. P2Y receptors present in the native and isolated rat glomerulus. Nephron Physiol 96:79-90, 2004.
18. Vitzthum H, Weiss B, Bachleitner W, Kramer BK, Kurtz A. Gene expression of adenosine receptors along the nephron. Kidney Int 65:1180-1190, 2004.
19. McCoy DE, Bhattacharya S, Olson BA, Levier DG, Arend LJ, Spielman WS. The renal adenosine system: structure, function, and regulation. Semin Nephrol 13:31-40, 1993.
20. Bailey MA, Hillman KA, Unwin RJ. P2 receptors in the kidney. J Auton Nerv Syst 81:264-270, 2000.
21. Inscho EW, Mitchell KD, Navar LG. Extracellular ATP in the regulation of renal microvascular function. FASEB J 8:319-328, 1994.
22. Inscho EW. Purinergic receptors in the glomerulus and vasculature of the kidney. Curr Top Membranes 54:453-478, 2003.
23. Schnermann J, Levine DZ. Paracrine factors in tubuloglomerular feedback: adenosine, ATP, and nitric oxide. Annu Rev Physiol 65:501-529, 2003.
24. Jackson EK, Raghvendra DK. The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66:571-599, 2004.
25. Vallon V, Muhlbauer B, Osswald H. Adenosine and kidney function. Physiol Rev 86:901-940, 2006.
26. Burnstock G, Campbell G, Satchell D, Smythe A. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40:668-688, 1970.
27. Burnstock G, Satchell DG, Smythe A. A comparison of the excitatory and inhibitory effects of non-adrenergic, non-cholinergic nerve stimulation and exogenously applied ATP on a variety of smooth muscle preparations from different vertebrate species. Br J Pharmacol 46:234-242, 1972.
28. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492, 1998.
29. Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. Structure and function of adenosine receptors and their genes. Naunyn Schmiedebergs Arch Pharmacol 362:364-374, 2000.
30. Illes P, Klotz KN, Lohse MJ. Signaling by extracellular nucleotides and nucleosides. Naunyn Schmiedebergs Arch Pharmacol 362:295-298, 2000.
31. Klotz KN. Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362:382-391, 2000.
32. 1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release. Mol Pharmacol 45:1036-1042, 1994.
33. 1-adenosine receptor. J Biol Chem 269:32077-32084, 1994.
34. 1 and bradykinin receptors increases protein kinase C and phospholipase D activity in smooth muscle cells. Naunyn Schmiedebergs Arch Pharmacol 351:186-193, 1995.
35. 3 adenosine receptor. J Biol Chem 270:16895-16902, 1995.
36. Hansen PB, Castrop H, Briggs J, Schnermann J. Adenosine induces vasoconstriction through Gi-dependent activation of phospholipase C in isolated perfused afferent arterioles of mice. J Am Soc Nephrol 14:2457-2465, 2003.
37. 2b receptor from human brain. Biochem Biophys Res Commun 187:86-93, 1992.
38. Olah ME. Identification of A2a adenosine receptor domains involved in selective coupling to Gs. Analysis of chimeric A1/A2a adenosine receptors. J Biol Chem 272:337-344, 1997.
39. von Kugelgen I, Wetter A. Molecular pharmacology of P2Y-receptors. Naunyn Schmiedebergs Arch Pharmacol 362:310-323, 2000.
40. Sak K, Webb TE. A retrospective of recombinant P2Y receptor subtypes and their pharmacology. Arch Biochem Biophys 397:131-136, 2002.
41. Pearson JD, Slakey LL, Gordon JL. Stimulation of prostaglandin production through purinoceptors on cultured porcine endothelial cells. Biochem J 214:273-276, 1983.
42. Pirotton S, Communi D, Motte S, Janssens R, Boeynaems JM. Endothelial P2-purinoceptors: subtypes and signal transduction. J Auton Pharmacol 16:353-356, 1996.
43. Van Der Giet M, Giebing G, Tolle M, Schmidt S. The role of P2Y receptors in the control of blood pressure. Drug News Perspect 15:640-646, 2002.
44. Inscho EW, Cook AK. P2 receptor-mediated afferent arteriolar vasoconstriction during calcium blockade. Am J Physiol Renal Physiol 282:F245-F255, 2002.
45. Sauzeau V, Le Jeune H, Cario-Toumaniantz C, Vaillant N, Gadeau AP, Desgranges C, Scalbert E, Chardin P, Pacaud P, Loirand G. P2Y(1), P2Y(2), P2Y(4), and P2Y(6) receptors are coupled to Rho and Rho kinase activation in vascular myocytes. Am J Physiol Heart Circ Physiol 278:H1751-H1761, 2000.
46. Chaulet H, Desgranges C, Renault MA, Dupuch F, Ezan G, Peiretti F, Loirand G, Pacaud P, Gadeau AP. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 89:772-778, 2001.
47. Burnstock G, Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16:433-440, 1985.
48. Benham CD, Tsien RW. A novel receptor-operated Ca2+-permeable channel activated by ATP in smooth muscle. Nature 328:275-278, 1987.
49. Khakh BS, Burnstock G, Kennedy C, King BF, North RA, Seguela P, Voigt M, Humphrey PP. International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. Pharmacol Rev 53:107-118, 2001.
50. Abbracchio MP, Burnstock G. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475, 1994.
51. Barnard EA, Simon J, Webb TE. Nucleotide receptors in the nervous system. An abundant component using diverse transduction mechanisms. Mol Neurobiol 15:103-129, 1997.
52. Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM. Advances in signalling by extracellular nucleotides. The role and transduction mechanisms of P2Y receptors. Cell Signal 12:351-360, 2000.
53. Ralevic V. Mechanism of prolonged vasorelaxation to ATP in the rat isolated mesenteric arterial bed. Br J Pharmacol 132:685-692, 2001.
54. Bo X, Burnstock G. Heterogeneous distribution of [3H]alpha,beta-methylene ATP binding sites in blood vessels. J Vasc Res 30:87-101, 1993.
55. Lewis CJ, Evans RJ. P2X receptor immunoreactivity in different arteries from the femoral, pulmonary, cerebral, coronary and renal circulations. J Vasc Res 38:332-340, 2001.
56. Inscho EW. Modulation of renal microvascular function by adenosine. Am J Physiol Regul Integr Comp Physiol 285:R23-R25, 2003.
57. Leipziger J. Control of epithelial transport via luminal P2 receptors. Am J Physiol Renal Physiol 284:F419-F432, 2003.
58. Schwiebert EM. ATP release mechanisms, ATP receptors and purinergic signalling along the nephron. Clin Exp Pharmacol Physiol 28:340-350, 2001.
59. Schwiebert EM, Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells. Biochim Biophys Acta 1615:7-32, 2003.
60. Weaver DR, Reppert SM. Adenosine receptor gene expression in rat kidney. Am J Physiol 263:F991-F995, 1992.
61. Smith JA, Sivaprasadarao A, Munsey TS, Bowmer CJ, Yates MS. Immunolocalisation of adenosine A(1) receptors in the rat kidney. Biochem Pharmacol 61:237-244, 2001.
62. Pawelczyk T, Grden M, Rzepko R, Sakowicz M, Szutowicz A. Region-specific alterations of adenosine receptors expression level in kidney of diabetic rat. Am J Pathol 167:315-325, 2005.
63. Jackson EK, Zhu C, Tofovic SP. Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 283:F41-F51, 2002.
64. Zou AP, Wu F, Li PL, Cowley AW Jr. Effect of chronic salt loading on adenosine metabolism and receptor expression in renal cortex and medulla in rats. Hypertension 33:511-516, 1999.
65. 1 purinoceptors by autoradiography and immunohistochemistry in rat kidneys. Am J Physiol 274:F799-F804, 1998.
66. Bailey MA, Imbert-Teboul M, Turner C, Marsy S, Srai K, Burnstock G, Unwin RJ. Axial distribution and characterization of basolateral P2Y receptors along the rat renal tubule. Kidney Int 58:1893-1901, 2000.
67. Rivera I, Zhang S, Fuller BS, Edwards B, Seki T, Wang MH, Marrero MB, Inscho EW. P2 receptor regulation of [Ca2+]i in cultured mouse mesangial cells. Am J Physiol Renal Physiol (in press), 2007.
68. Drury A, Szent-Gyorgyi A. The physiological activity of adenosine compounds with special reference to their action upon mammalian heart. J Physiol (London) 68:213-226, 1929.
69. Osswald H. Renal effects of adenosine and their inhibition by theophylline in dogs. Naunyn Schmiedebergs Arch Pharmacol 288:79-86, 1975.
70. Osswald H, Spielman WS, Knox FG. Mechanism of adenosine-mediated decreases in glomerular filtration rate in dogs. Circ Res 43:465-469, 1978.
71. Holz FG, Steinhausen M. Renovascular effects of adenosine receptor agonists. Ren Physiol 10:272-282, 1987.
72. Inscho EW, Carmines PK, Navar LG. Juxtamedullary afferent arteriolar responses to P1 and P2 purinergic stimulation. Hypertension 17:1033-1037, 1991.
73. Ibarrola AM, Inscho EW, Vari RC, Navar LG. Influence of adenosine receptor blockade on renal function and renal autoregulation. J Am Soc Nephrol 2:991-999, 1991.
74. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. Vasomotor effects of purinergic agonists in isolated rabbit afferent arterioles. Am J Physiol 263:F1026-F1033, 1992.
75. Weihprecht H, Lorenz JN, Briggs JP, Schnermann J. Synergistic effects of angiotensin and adenosine in the renal microvasculature. Am J Physiol 266:F227-F239, 1994.
76. Carmines PK, Inscho EW. Renal arteriolar angiotensin responses during varied adenosine receptor activation. Hypertension 23(Supp 1):I114-I119, 1994.
77. Kawabata M, Ogawa T, Takabatake T. Control of rat glomerular microcirculation by juxtaglomerular adenosine A1 receptors. Kidney Int Suppl 67:S228-230, 1998.
78. 1A receptor-deficient mice. Am J Physiol 275:F922-F927, 1998.
79. Yaoita H, Ito O, Arima S, Endo Y, Takeuchi K, Omata K, Ito S. Effect of adenosine on isolated afferent arterioles. Nippon Jinzo Gakkai Shi 41:697-703, 1999.
80. 2 adenosine receptors. J Pharmacol Exp Ther 315:1150-1157, 2005.
81. 1 receptor antagonist, on renal hemodynamics and urine formation in anesthetized dogs. Pharmacology 55:193-201, 1997.
82. Okumura M, Miura K, Yamashita Y, Yukimura T, Yamamoto K. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs. J Pharmacol Exp Ther 260:1262-1267, 1992.
83. 2 receptor on renal function and renin release in dogs. Jpn J Pharmacol 80:173-176, 1999.
84. 2a receptors on renal microvascular reactivity. Am J Physiol Renal Physiol 280:F406-F414, 2001.
85. Ren Y, Garvin JL, Carretero OA. Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int 59:222-229, 2001.
86. Inscho EW, Ohishi K, Navar LG. Effects of ATP on pre- and postglomerular juxtamedullary microvasculature. Am J Physiol 263:F886-F893, 1992.
87. Inscho EW. Renal microvascular effects of P2 receptor stimulation. Clin Exp Pharmacol Physiol 28:332-339, 2001.
88. Eppel GA, Ventura S, Denton KM, Evans RG. Lack of contribution of P2X receptors to neurally mediated vasoconstriction in the rabbit kidney in vivo. Acta Physiol (Oxf) 186:197-207, 2006.
89. Churchill PC, Ellis VR. Pharmacological characterization of the renovascular P2 purinergic receptors. J Pharmacol Exp Ther 265:334-338, 1993.
90. Eltze M, Ullrich B. Characterization of vascular P2 purinoceptors in the rat isolated perfused kidney. Eur J Pharmacol 306:139-152, 1996.
91. Inscho EW, Cook AK, Mui V, Miller J. Direct assessment of renal microvascular responses to P2-purinoceptor agonists. Am J Physiol 274:F718-F727, 1998.
92. Wangensteen R, Fernandez O, Sainz J, Quesada A, Vargas F, Osuna A. Contribution of endothelium-derived relaxing factors to P2Y-purinoceptor-induced vasodilation in the isolated rat kidney. Gen Pharmacol 35:129-133, 2000.
93. Inscho EW, Ohishi K, Cook AK, Belott TP, Navar LG. Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am J Physiol 268:F876-F884, 1995.
94. Inscho EW, Belott TP, Mason MJ, Smith JB, Navar LG. Extracellular ATP increases cytosolic calcium in cultured rat renal arterial smooth muscle cells. Clin Exp Pharmacol Physiol 23:503-507, 1996.
95. Inscho EW, Schroeder AC, Deichmann PC, Imig JD. ATP-mediated Ca2+ signaling in preglomerular smooth muscle cells. Am J Physiol 276:F450-F456, 1999.
96. Gutierrez AM, Kornfeld M, Persson AE. Calcium response to adenosine and ATP in rabbit afferent arterioles. Acta Physiol Scand 166:175-181, 1999.
97. Guyton AC, Cowley AW Jr., Young DB, Coleman TG, Hall JE, DeClue JW. Integration and control of circulatory function. Int Rev Physiol 9:341-385, 1976.
98. Vallon V. Tubuloglomerular feedback and the control of glomerular filtration rate. News Physiol Sci 18:169-174, 2003.
99. Osswald H, Muhlbauer B, Vallon V. Adenosine and tubuloglomerular feedback. Blood Purif 15:243-252, 1997.
100. 1 receptors in renal microvascular autoregulatory behavior. J Clin Invest 112:1895-1905, 2003.
101. Schnermann J, Weihprecht H, Briggs JP. Inhibition of tubuloglomerular feedback during adenosine1 receptor blockade. Am J Physiol 258:F553-F561, 1990.
102. Thomson S, Bao D, Deng A, Vallon V. Adenosine formed by 5′-nucleotidase mediates tubuloglomerular feedback. J Clin Invest 106:289-298, 2000.
103. Ren Y, Arima S, Carretero OA, Ito S. Possible role of adenosine in macula densa control of glomerular hemodynamics. Kidney Int 61:169-176, 2002.
104. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, Schnermann J. Mediation of tubuloglomerular feedback by adenosine: evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci U S A 98:9983-9988, 2001.
105. 1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281:R1362-R1367, 2001.
106. 1 receptors and tubuloglomerular feedback in mice. Pflugers Arch 448:214-221, 2004.
107. Hashimoto S, Huang Y, Briggs J, Schnermann J. Reduced autoregulatory effectiveness in adenosine 1 receptor-deficient mice. Am J Physiol Renal Physiol 290:F888-F891, 2006.
108. Premen AJ, Hall JE, Mizelle HL, Cornell JE. Maintenance of renal autoregulation during infusion of aminophylline or adenosine. Am J Physiol 248:F366-F373, 1985.
109. Mitchell KD, Navar LG. Modulation of tubuloglomerular feedback responsiveness by extracellular ATP. Am J Physiol 264:F458-F466, 1993.
110. Inscho EW, Cook AK, Navar LG. Pressure-mediated vasoconstriction of juxtamedullary afferent arterioles involves P2-purinoceptor activation. Am J Physiol 271:F1077-F1085, 1996.
111. Majid DS, Inscho EW, Navar LG. P2 purinoceptor saturation by adenosine triphosphate impairs renal autoregulation in dogs. J Am Soc Nephrol 10:492-498, 1999.
112. Nishiyama A, Majid DS, Walker M 3rd, Miyatake A, Navar LG: Renal interstitial ATP responses to changes in arterial pressure during alterations in tubuloglomerular feedback activity. Hypertension 37:753-759, 2001.
113. Nishiyama A, Jackson KE, Majid DS, Rahman M, Navar LG. Renal interstitial fluid ATP responses to arterial pressure and tubuloglomerular feedback activation during calcium channel blockade. Am J Physiol Heart Circ Physiol 290:H772-H777, 2006.
114. Liu R, Bell PD, Peti-Peterdi J, Kovacs G, Johansson A, Persson AE. Purinergic receptor signaling at the basolateral membrane of macula densa cells. J Am Soc Nephrol 13:1145-1151, 2002.
115. Bell PD, Lapointe JY, Peti-Peterdi J. Macula densa cell signaling. Annu Rev Physiol 65:481-500, 2003.
116. Komlosi P, Peti-Peterdi J, Fuson AL, Fintha A, Rosivall L, Bell PD. Macula densa basolateral ATP release is regulated by luminal [NaCl] and dietary salt intake. Am J Physiol Renal Physiol 286:F1054-F1058, 2004.
117. Bell PD, Lapointe JY, Sabirov R, Hayashi S, Peti-Peterdi J, Manabe K, Kovacs G, Okada Y. Macula densa cell signaling involves ATP release through a maxi anion channel. Proc Natl Acad Sci U S A 100:4322-4327, 2003.
118. Nishiyama A, Majid DS, Taher KA, Miyatake A, Navar LG. Relation between renal interstitial ATP concentrations and autoregulation-mediated changes in renal vascular resistance. Circ Res 86:656-662, 2000.
119. Takenaka T, Harrison-Bernard LM, Inscho EW, Carmines PK, Navar LG. Autoregulation of afferent arteriolar blood flow in juxtamedullary nephrons. Am J Physiol 267:F879-F887, 1994.
120. Walker M, 3rd, Harrison-Bernard LM, Cook AK, Navar LG. Dynamic interaction between myogenic and TGF mechanisms in afferent arteriolar blood flow autoregulation. Am J Physiol Renal Physiol 279:F858-F865, 2000.
121. Peti-Peterdi J. Calcium wave of tubuloglomerular feedback. Am J Physiol Renal Physiol 291:F473-F480, 2006.
122. Castrop H, Huang Y, Hashimoto S, Mizel D, Hansen P, Theilig F, Bachmann S, Deng C, Briggs J, Schnermann J. Impairment of tubuloglomerular feedback regulation of GFR in ecto-59-nucleotidase/CD73-deficient mice. J Clin Invest 114:634-642, 2004.
123. Huang DY, Vallon V, Zimmermann H, Koszalka P, Schrader J, Osswald H. Ecto-59-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo. Am J Physiol Renal Physiol 291:F282-F288, 2006.
124. Boim MA, Stella SR, Pereira AB, Schor N. Heterogeneity of glomerular perfusion and filtration induced by epinephrine and norepinephrine. Braz J Med Biol Res 30:1023-1031, 1997.
125. Sjoquist M, Goransson A, Kallskog O, Ulfendahl HR. The influence of tubulo-glomerular feedback on the autoregulation of filtration rate in superficial and deep glomeruli. Acta Physiol Scand 122:235-242, 1984.
126. Ren Y, Garvin JL, Liu R, Carretero OA. Role of macula densa adenosine triphosphate (ATP) in tubuloglomerular feedback. Kidney Int 66:1479-1485, 2004.
127. Inscho EW, Carmines PK, Cook AK, Navar LG. Afferent arteriolar responsiveness to altered perfusion pressure in renal hypertension. Hypertension 15:748-752, 1990.
128. Inscho EW, Imig JD, Deichmann PC, Cook AK. Candesartan cilexetil protects against loss of autoregulatory efficiency in angiotensin II-infused rats. J Am Soc Nephrol 10(Suppl 11):S178-S183, 1999.
129. Anderson WP, Kett MM, Stevenson KM, Edgley AJ, Denton KM, Fitzgerald SM. Renovascular hypertension: structural changes in the renal vasculature. Hypertension 36:648-652, 2000.
130. Fitzgerald SM, Evans RG, Bergstrom G, Anderson WP. Renal hemodynamic responses to intrarenal infusion of ligands for the putative angiotensin IV receptor in anesthetized rats. J Cardiovasc Pharmacol 34:206-211, 1999.
131. Imig JD, Inscho EW. Adaptations of the renal microcirculation to hypertension. Microcirculation 9:315-328, 2002.
132. Persson PB. Renal blood flow autoregulation in blood pressure control. Curr Opin Nephrol Hypertens 11:67-72, 2002.
133. Racasan S, Joles JA, Boer P, Koomans HA, Braam B. NO dependency of RBF and autoregulation in the spontaneously hypertensive rat. Am J Physiol Renal Physiol 285:F105-F112, 2003.
134. Welch WJ. Adenosine type 1 receptor antagonists in fluid retaining disorders. Expert Opin Investig Drugs 11:1553-1562, 2002.
135. Vonend O, Turner CM, Chan CM, Loesch A, Dell'Anna GC, Srai KS, Burnstock G, Unwin RJ. Glomerular expression of the ATP-sensitive P2X receptor in diabetic and hypertensive rat models. Kidney Int 66:157-166, 2004.
136. Liu R, Persson AE. Effects of nitric oxide on P2Y receptor resensitization in spontaneously hypertensive rat mesangial cells. J Hypertens 20:1835-1842, 2002.
137. 2+ signaling attenuates P2X receptor-mediated vasoconstriction of afferent arterioles in angiotensin II hypertension. Hypertension 46:562-568, 2005.
138. Wang CT, Chin SY, Navar LG. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 279:F319-F325, 2000.
139. 1 receptor mRNA in microdissected rat nephron segments. Hypertension 26:1181-1185, 1995.
140. Hansen MA, Dutton JL, Balcar VJ, Barden JA, Bennett MR. P2X (purinergic) receptor distributions in rat blood vessels. J Auton Nerv Syst 75:147-155, 1999.
141. Hillman KA, Johnson TM, Winyard PJ, Burnstock G, Unwin RJ, Woolf AS. P2X(7) receptors are expressed during mouse nephrogenesis and in collecting duct cysts of the cpk/cpk mouse. Exp Nephrol 10:34-42, 2002.
142. Kishore BK, Ginns SM, Krane CM, Nielsen S, Knepper MA. Cellular localization of P2Y(2) purinoceptor in rat renal inner medulla and lung. Am J Physiol Renal Physiol 278:F43-F51, 2000.
143. Bailey MA, Imbert-Teboul M, Turner C, Srai SK, Burnstock G, Unwin RJ. Evidence for basolateral P2Y(6) receptors along the rat proximal tubule: functional and molecular characterization. J Am Soc Nephrol 12:1640-1647, 2001.